PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy
about
SF-36 total score as a single measure of health-related quality of life: Scoping reviewManagement of Hypoparathyroidism: Present and Future.Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidismParathyroid hormone therapy for hypoparathyroidismPTH(1-84) replacement therapy for the treatment of hypoparathyroidism.PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in NorwayEffects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study.Review of Hypoparathyroidism.Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.Natpara for the treatment of hypoparathyroidism.Drug safety evaluation of parathyroid hormone for hypocalcemia in patients with hypoparathyroidism.Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review.Recombinant Parathyroid Hormone Versus Usual Care: Do the Outcomes Justify the Cost?Clinical profile and long-term follow-up of 32 patients with postoperative permanent hypoparathyroidism.Quality of life in hypoparathyroidism.Vitamin D and calcium supplementation, skeletal muscle strength and serum testosterone in young healthy adult males: Randomized control trial.Hypoparathyroidism.
P2860
Q28066146-76EE966F-8116-4B9A-93EC-9EECBCBE9B02Q33570607-03211D87-8E61-40C2-A906-C7EE17A90248Q33609120-0285F863-5A1E-4AEF-8E7C-4E973649C925Q35014795-1E827F3F-1D34-40C8-AEE5-CD024450595DQ35100381-F25EA7FC-2235-4FAE-B876-3E417D73AC59Q36795949-19DFB1DA-435C-4F46-929F-E2F88728DC02Q37147509-3BBD0394-2C44-49B5-AB1C-A7A8502E9968Q37578427-05155750-3266-4EE2-815B-BF23D6048173Q37587224-2081E335-FF62-47ED-ACA3-43DA79F34B07Q38547732-B562D0E9-4CCC-40A8-8BAB-D84842A69BDEQ38816021-99EEBB89-2901-462E-B541-FD02A0A8BF33Q38884368-62BA8646-C6AF-40BB-BAD1-4C73B7EED618Q40077839-C2AFACE4-5C08-491C-B76C-662F9BE605CCQ46438384-B6D3F604-7333-4B3F-BF73-D917D682D15CQ47555326-3AF2F11C-3C3A-400D-97EA-132108D75F67Q48226218-A58297F3-6DFA-4140-9EDD-A00E30CD8BA8Q48376565-D5E33DCC-661A-4872-9A74-6A5CA3EB9388Q51799713-7BDC7181-F38A-4ED2-AAB2-E18D4DD86B85
P2860
PTH(1-84) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
PTH(1-84) is associated with i ...... ism through 5 years of therapy
@ast
PTH(1-84) is associated with i ...... ism through 5 years of therapy
@en
type
label
PTH(1-84) is associated with i ...... ism through 5 years of therapy
@ast
PTH(1-84) is associated with i ...... ism through 5 years of therapy
@en
prefLabel
PTH(1-84) is associated with i ...... ism through 5 years of therapy
@ast
PTH(1-84) is associated with i ...... ism through 5 years of therapy
@en
P2093
P2860
P356
P1476
PTH(1-84) is associated with i ...... ism through 5 years of therapy
@en
P2093
Dinaz Irani
Donald J McMahon
Elizabeth Levy
Laura Anderson
Mishaela R Rubin
Natalie E Cusano
P2860
P304
P356
10.1210/JC.2014-2267
P407
P577
2014-06-30T00:00:00Z